Peter MacCallum Cancer Centre researcher Dr Dane Cheasley (pictured) has been awarded a $1.1 million dollar four-year grant from the …
Low-grade serous ovarian cancer advocates receive national award
Jeanie Ferris Cancer Australia Award On the 26th of June 2020 two exceptional members of our low-grade serous ovarian cancer …
Woman continues to honour sister’s dying wish
It’s been six months since Elsa Larsen lost her sister Kristen to ovarian cancer. She was just 27 years old. …
Ovarshare this February
Ovarian Cancer Awareness Month 2020 February is Ovarian Cancer Awareness Month in Australia. Every day 4 women will be diagnosed …
Our incredible advocate
A recent article and video by 10 Daily has highlighted the need for more research funding, and awareness of ovarian …
Coping with cancer at Christmas
It’s November and already that time of year again when the Christmas adverts appear on TV and the shops are …
Binimetinib in low-grade serous carcinoma
A phase II study of Selumetinib, an oral small-molecule inhibitor of MEK1/2, has shown promising results in patients with recurrent …
Giving CuresDay on Giving Tuesday
Cure Our Ovarian Cancer is Celebrating GivingTuesday in Australia with #GivingCuresDay joining millions around the world participating in the global …
Visit to Sydney low-grade serous research laboratory
Cure Our Ovarian Cancer enjoyed our visit to the Westmead Institute for Medical Research in Sydney this week. We were …
Study Shows Trametinib Improves Outcomes for Women with Low-Grade Serous Carcinoma of the Ovary/Peritoneum on NRG Oncology Trial
Results from GOG 0281, a randomised phase II/III clinical trial, were presented by Dr Gershenson on Sunday at the European …